Stockfacts
Use CasesDocsPricing
Log inSign up free
OverviewFinancialsTrendsTranscriptsOptionsShortsInstitutionsInsidersCorporate ActionsSEC Filings
Stockfacts

EOD US-equity data for investors and AI agents

Data is end-of-day, not real-time, and not investment advice

Use CasesDashboard

TVTX

Travere Therapeutics, Inc.

CIK 0001438533 · Nasdaq

NasdaqHealth CarePharmaceutical Preparations
$65.71
↑ 1.25 (1.94%)
as of Aug 21, 2026
End-of-day close, not real-time intraday
Live price (Google Finance) ↗
Overall read: NeutralOverall score · based on 4/4 lenses
FundamentalsOwnershipTechnicalsOptions

Bullish: Ownership, Technicals; Risks: Options

Key stats

Market Cap
$6.19B
P/E Ratio
-142.51
EPS
-0.29
Dividend Yield
Not covered
52W Position
99%
Beta
1.49

Valuation multiples

Fwd P/E
76.34
PEG
Not covered
P/B
252.59
P/S
10.47
EV/Revenue
10.28
ROE
-177.2%
Valuation data covers 8,711/9,697 US-listed stocks (89.8%).

Price · 1Y

251 trading days

End-of-day close, not real-time intraday

52-Week RangePosition 99%
$17.05$66.38

Latest Financials

2025-12-31 FY
Revenue
$490.73M
Net Income
-$25.55M
Total Assets
$605.19M
Free Cash Flow
–

Recent news